Buy SLU-PP-332 in Australia
Buy SLU-PP-332 in Australia from Macropus Peptides as a 5mg research vial, priced and ready to order. SLU-PP-332 is a synthetic, non-steroidal small molecule that activates the three oestrogen-related receptors, ERR alpha, beta and gamma, with the greatest potency at ERR alpha. These orphan nuclear receptors control genes for mitochondrial biogenesis and oxidative metabolism, so the compound gives laboratories a direct chemical switch for that programme in cell and animal models. Each vial holds the compound as a dry solid, labelled with name, strength, lot number and storage temperature, and a certificate of analysis is available for every lot. Buying several vials in one order keeps a study on the same lot. Order online and your parcel is dispatched from within Australia to any Australian address. SLU-PP-332 is sold to adults aged 18 and over for in-vitro laboratory research only, not for human or veterinary use.
| Compound | SLU-PP-332 |
|---|---|
| Amount | 5 mg |
| Form | Lyophilised powder |
| Category | Metabolic research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
SLU-PP-332 5mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy SLU-PP-332 Australia: 5mg Research Vial
Macropus Peptides supplies this ERR agonist as a 5mg vial at a fixed price, ready to order. Chemically it is a small organic molecule, yet it belongs in our metabolic range because so many studies run it next to mitochondrial and incretin peptides, and each vial is lot-released from one supply.
SLU-PP-332 Australia: what the compound is
It is a synthetic, non-steroidal agonist of the oestrogen-related receptors, developed through medicinal chemistry on an earlier ERR ligand scaffold. The prefix reflects the university where the compound series was made. Structurally it is a compact aromatic acylhydrazone, and it is handled as an ordinary organic research compound: stored dry and dissolved in a suitable solvent before use, rather than reconstituted like a lyophilised peptide. It is purely preclinical, with no clinical development record.
Its chemical name is 4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide, formula C18H14N2O2, with a molecular weight of about 290. That low weight means the 5mg vial holds roughly 17 micromoles of compound, far more molecules than the same mass of any peptide in our range. The acylhydrazone link can hydrolyse slowly in acidic water, one more reason laboratories make an organic solvent stock first and prepare aqueous dilutions on the day.
SLU-PP-332 ERR agonist: how it works in research
The oestrogen-related receptors ERR alpha, ERR beta and ERR gamma are orphan nuclear receptors. They carry the oestrogen name but bind no oestrogen, and no natural hormone ligand has been confirmed for them. They drive transcription of genes for mitochondrial biogenesis, fatty acid oxidation and oxidative phosphorylation, largely working with the coactivator PGC-1 alpha. The compound activates all three subtypes, most potently ERR alpha, which gives researchers one of very few direct chemical tools for switching this transcriptional programme on. It is used in skeletal muscle cells, hepatocytes and mouse models to study mitochondrial gene expression and respiration, and it pairs naturally with MOTS-C, which acts on energy sensing through AMPK instead. Because activity at the beta and gamma subtypes needs higher concentrations than at ERR alpha, well designed experiments add a subtype knockdown or an ERR alpha inverse agonist to show which receptor carries a given result.
SLU-PP-332 research: what the published studies show
Its pharmacology was characterised in ACS Chemical Biology in 2023, where it was tested in muscle cells and mice and its effect on oxidative gene expression was shown to depend on ERR alpha. A 2024 pharmacology paper in JPET examined it in diet-induced and genetic mouse models of metabolic syndrome, measuring glucose tolerance and energy expenditure. The 2023 work also compared the gene expression pattern it produced in muscle cells with the pattern seen after exercise, which is why the literature calls it an exercise mimetic, a label describing transcriptional signatures in models rather than any effect in people. Both are preclinical studies, and both are summarised in our SLU-PP-332 research studies library.
SLU-PP-332 vial specifications
| Specification | Detail |
|---|---|
| Compound | SLU-PP-332 |
| Amount | 5 mg |
| Form | Lyophilised powder |
| Category | Metabolic research |
| Storage | -20 °C, protect from light |
A dry solid of the pan-ERR agonist sits under the crimped cap. Compound, 5mg content, lot and storage temperature are printed on the glass; forward the lot and its analysis certificate follows. Store the vial at -20 °C, protected from light and moisture. Being a dry organic solid rather than a freeze-dried cake, it may sit as loose powder or a thin film on the glass, so tap the vial on the bench before opening and run solvent down the wall to collect every trace before capping and vortexing briefly.
SLU-PP-332 price in Australia
| Strength | Price | Price per mg |
|---|---|---|
| SLU-PP-332 5mg | $109.99 | $22.00 per mg |
A single fixed price covers the 5mg vial; divide it by five for the cost per milligram. Ordering two or more vials together is the usual way to extend a study without a lot change. The small molecule also stretches a long way: dissolved to a 10 millimolar stock, one vial supplies well over a litre of culture medium at a working concentration of 10 micromolar, so the cost of each plate stays small.
SLU-PP-332 5mg: where to buy in Australia
One vial supports reporter assays, gene expression panels and short culture experiments. Aromatic small molecules like this typically have limited solubility in water, so most protocols dissolve them first in an organic solvent such as DMSO and then dilute into media; follow the method your study specifies. Stock strengths:
- 0.5 mL: 10 mg per mL
- 1 mL: 5 mg per mL
- 1.72 mL: 10 millimolar, a round figure for DMSO stocks
Best place to buy SLU-PP-332 Australia
- Sold online at macropuspeptides.com, priced at $109.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to buy SLU-PP-332 online
- Add the 5mg vial to your cart
- Order enough vials to hold the study on one lot
- Check the solvent your protocol names and add supplies
- Pay, stating your age and research purpose
- Keep the lot code and request its analysis certificate
SLU-PP-332 calculator: making a stock from 5mg
The calculator on the listing turns a solvent volume into milligram and microgram strengths. For this vial:
- 0.5 mL: 10 mg per mL
- 1 mL: 5 mg per mL
- 2 mL: 2.5 mg per mL
DMSO pulls moisture from the air, so cap stock tubes tightly and hold them in a sealed box at -20 °C, because absorbed water can push the compound out of solution. Working concentrations in cell media are then set by further dilution from that stock. Solvents and consumables are in lab supplies, and the starter kit adds bacteriostatic water, ten syringes and twenty swabs to one 5mg vial.
Is SLU-PP-332 available in Australia
It is available as a research compound only. The ERR agonist has no ARTG entry and has never won TGA approval. That keeps it out of human and animal use entirely; our buyers work with it in-vitro. Chemical scheduling is set by the Poisons Standard, which gets revised, so look up the present entry for your own organisation.
SLU-PP-332 for sale Australia wide
Orders are packed in Australia and dispatched to laboratories in each capital and in regional centres. The compound is also listed as SLU-PP-332 capsules, and it features with 5-Amino-1MQ and MOTS-C in the metabolic trio. Every other tool in the metabolic research range can join the same parcel.
References
- Synthetic ERRalpha/beta/gamma agonist induces an ERRalpha-dependent acute aerobic exercise response and enhances exercise capacity. ACS Chemical Biology. 2023.
- A synthetic ERR agonist alleviates metabolic syndrome. Journal of Pharmacology and Experimental Therapeutics. 2024.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.